MedPath

INSTITUTE OF LIVER AND BILIARY SCIENCES

INSTITUTE OF LIVER AND BILIARY SCIENCES logo
🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Efficacy and Safety of Plasma Exchange Compared to Standard Medical Therapy in Patients With Severe Drug Induced Liver Injury With or Without Underlying Chronic Liver Disease.

Not Applicable
Conditions
Chronic Liver Disease
Interventions
Biological: High Volume Plasma Exchange
Other: Standard Medical Treatment
First Posted Date
2019-07-11
Last Posted Date
2019-07-11
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
30
Registration Number
NCT04015570
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Efficacy and Safety of Early TIPS (Transjugular Intrahepatic Portosystemic Shunts) in the Management of Cirrhosis With Recurrent Ascites.

Not Applicable
Conditions
Liver Cirrhoses
Interventions
Procedure: Transjugular Intrahepatic Portosystemic Shunt
Other: Standard Medical Treatment
First Posted Date
2019-07-09
Last Posted Date
2019-08-28
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
80
Registration Number
NCT04013074
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Efficacy and Safety of Hemoperfusion or Plasma Exchange Compared to Standard Medical Therapy in Patients With Acute on Chronic Liver Failure

Not Applicable
Conditions
Acute-On-Chronic Liver Failure
Interventions
Drug: Standard Medical Treatment
Drug: Haemoperfusion
Other: Plasma Exchange
First Posted Date
2019-07-09
Last Posted Date
2019-07-10
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
250
Registration Number
NCT04013113
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Efficacy and Safety of Testosterone Therapy in Improving Sarcopenia in Men With Cirrhosis.

Not Applicable
Conditions
Liver Cirrhosis
Interventions
Drug: Standard Medical Treatment
Other: Exercise
First Posted Date
2019-06-24
Last Posted Date
2019-08-21
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
100
Registration Number
NCT03995251
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Indirect Calorimeter Based Study in Patients With Liver Cirrhosis

Not Applicable
Completed
Conditions
Liver Cirrhoses
Interventions
Other: Indirect calorimetry based nutritional intervention till patient in ICU(Intensive care unit)
Other: Standard and fixed nutritional intervention till patient in ICU
First Posted Date
2019-03-12
Last Posted Date
2022-10-24
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
83
Registration Number
NCT03871894
Locations
🇮🇳

ILBS, New Delhi, Delhi, India

Safety and Efficacy of Extracorporeal Cytokine Hemoadsorption in Septic Shock in Critically Ill Cirrhotics

Not Applicable
Conditions
Septic Shock
Interventions
Drug: Extracorporeal Cytokine hemadsorption therapy
Drug: Standard Medical Treatment
First Posted Date
2019-03-07
Last Posted Date
2019-05-01
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
50
Registration Number
NCT03866083
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Propofol for Sedation of Postoperative Electively Ventilated Liver Transplant Recipients.

Conditions
Liver Cirrhoses
First Posted Date
2019-02-12
Last Posted Date
2019-02-12
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
30
Registration Number
NCT03837145
Locations
🇮🇳

Institute of liver and biliary sciences, New Delhi, Delhi, India

To Study the Efficacy and Safety of TIPS (Trans Intrahepatic Portosystemic Shunt) Versus Self Expanding Metallic Stent (SEMS) in the Management of Refractory Variceal Bleed in Cirrhotics.

Not Applicable
Conditions
Liver Cirrhoses
Interventions
Procedure: Self Expanding Metallic Stent
Procedure: Trans Intrahepatic Portosystemic Shunt
Drug: Vasoactive Agent
First Posted Date
2019-02-01
Last Posted Date
2020-03-10
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
50
Registration Number
NCT03827681
Locations
🇮🇳

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Comparison of 9 Doses vs 3 Doses of Post Operative Antibiotics in Live Liver Donors

Not Applicable
Completed
Conditions
Antibiotic Prophylaxis
Postoperative Infection
Interventions
First Posted Date
2018-12-05
Last Posted Date
2021-02-04
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
126
Registration Number
NCT03765645
Locations
🇮🇳

ILBS, New Delhi, Delhi, India

N-Acetyl Cysteine in the Prevention of Contrast Induced Nephropathy in Cirrhosis of Liver-NEPHRO Trial

Not Applicable
Completed
Conditions
Liver Cirrhoses
Interventions
Drug: Placebo Oral Tablet
First Posted Date
2018-11-29
Last Posted Date
2019-11-04
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
100
Registration Number
NCT03759158
Locations
🇮🇳

Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

© Copyright 2025. All Rights Reserved by MedPath